EXOME: Biotech • Healthcare • Life Sciences

Boston
Moderna Publishes Early COVID-19 Vaccine Data, Preps for Phase 3 Test

Boston
Last Chance for Xconomy Awards Nominations – Deadline is Friday, July 17
San Diego
After Biologic COVID-19 Drug OK’d in India, Equillium Plans a US Test
Boston
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact

1.
Moderna Publishes Early COVID-19 Vaccine Data, Preps for Phase 3 Test | Boston
2.
Last Chance for Xconomy Awards Nominations – Deadline is Friday, July 17 | Boston
3.
Dewpoint, Merck Team Up to Tackle HIV Using Condensate Know-How | Boston
4.
After Biologic COVID-19 Drug OK’d in India, Equillium Plans a US Test | San Diego
5.
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact | Boston
6.
New Xconomy Podcast & Special Report Feature Boston Biophama Leaders on Digital Health | Boston

Learn about the Xconomists →

Alexis Peyroles

Creating Consistent Value in Biotech Without Diluting Stakeholders

Andy Smith

Lax Approval Requirements Yield Blockbusters That Don’t Work

More Opinion, Insight, and Analysis ›

The 2020 National Xconomy Awards

September 24, 2020

$775M

Roche/Blueprint Medicines

Scholar Rock CEO Mahanthappa to Step Down, Kingsley Named Successor

Vor Biopharma Makes Slapak’s Chief Medical Officer Job Permanent

Amgen Doubles Down on BeiGene Collaboration, Investing $421M More
Sarah de Crescenzo | San Francisco
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments
Sarah de Crescenzo | National
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More
Sarah de Crescenzo | National
Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership
Sarah de Crescenzo | Boston
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep
Frank Vinluan | Philadelphia
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs
Sarah de Crescenzo | San Diego
Biogen Alzheimer’s Drug in FDA’s Court Following Completion of Filing
Sarah de Crescenzo | Boston
The 2020 National Xconomy Awards Expands, Goes Virtual & Reopens Nomination Period
Editors | National
Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck
Sarah de Crescenzo | Boston

Read More Posts ›

Underwriters and Partners

Xconomy Insight

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Sponsored · Whitepaper
COVID-19 Special Report: Sustaining Clinical Research During the Crisis
Leveraging technology & expertise to ensure a continual journey from trials to treatments
PRA Health Sciences

From Our Editors · Special Report
Containing Coronavirus Through Innovation and Investment
Top biotech and investment players offer their best plans and current progress in stemming and ultimately defeating the worldwide pandemic

Xconomy on Demand

We offer a number of ways to subscribe for free!